Suchergebnisse - "Follmann, Dean"

PubPharm (16)

1

Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults : a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial

enthalten in: The Lancet. Respiratory medicine | 2023

von Dayan, G. | Rouphael, N. | Walsh, S. | +120

2

Cross-direct effects in settings with two mediators

enthalten in: Biostatistics (Oxford, England) | 2023

von Gabriel, E. | Sjölander, A. | Follmann, D. | +1

3

Risk of COVID-19 after natural infection or vaccination

enthalten in: EBioMedicine | 2023

von Rick, A. | Laurens, M. | Huang, Y. | +125

4

Modifiers of COVID-19 vaccine efficacy : Results from four COVID-19 prevention network efficacy trials

enthalten in: Vaccine | 2023

von Turley, C. | Tables, L. | Fuller, T. | +33

5

Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults : A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials

enthalten in: JAMA network open | 2023

von Theodore, D. | Branche, A. | Zhang, L. | +128

6

Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration

enthalten in: Nature communications | 2023

von Follmann, D. | O'Brien, M. | Fintzi, J. | +21

7

Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial

enthalten in: Nature communications | 2023

von Fong, Y. | Huang, Y. | Benkeser, D. | +37

ErratumIn: Nat Commun. 2023 Mar 22;14(1):1581. - PMID 36949083

8

Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials

enthalten in: JAMA network open | 2023

von Mena Lora, A. | Long, J. | Huang, Y. | +125

ErratumIn: JAMA Netw Open. 2023 May 1;6(5):e2317317. - PMID 37213108

9

A Covid-19 Milestone Attained - A Correlate of Protection for Vaccines

enthalten in: The New England journal of medicine | 2022

von Gilbert, P. | Donis, R. | Koup, R. | +3

10

Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial

enthalten in: Annals of internal medicine | 2022

von Follmann, D. | Janes, H. | Buhule, O. | +10